# Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

> **NCT03654131** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 100 (actual)

## Conditions studied

- Colorectal Carcinoma
- Liver Metastases

## Interventions

- **DEVICE:** MWA
- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT03654131
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-07-25
- **Primary completion:** 2026-01-01
- **Final completion:** 2029-12-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03654131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03654131, "Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03654131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*